Tibetan Medicine's Eight-Ingredient Agarwood Powder: What Do the Coronary Heart Disease Clinical Data Really Show?

The literature on agarwood for 'heart disease' is remarkably clear: the Song dynasty Shengji Zonglu records agarwood decoction 'for chronic heart pain,' the Taiping Huimin Hejiju Fang's Suhexiang Pill contains agarwood for sudden heart pain, and Tibetan medicine's Four Tantras states 'eight ingredients with agarwood can treat heart trauma'—the eight-ingredient agarwood powder has been in continuous use for over a thousand years and remains an essential Tibetan medicine treatment for heart disease, included in China's ethnic medicine standards. The 62 papers in the Collected Literature on Agarwood and Heart Disease Research map out modern research in this direction.

1. Clinical Research: Concentrated in Ethnic Medicine Formulas

Mongolian medicine clinical trials: an 80-case randomized controlled trial showed the eight-ingredient agarwood powder group had a higher total effective rate than the conventional symptomatic treatment group, with significant improvements in angina attack frequency and duration, and better improvement in serum CRP, IL-6 and other inflammatory markers (Chinese Journal of Ethnic Medicine, 2021); a 76-case randomized parallel controlled trial showed the eight-ingredient agarwood powder plus isosorbide dinitrate group had a total symptom effective rate of 92.11% versus 68.42% for isosorbide dinitrate alone (2018); in a 90-case study, Guanxin Shutong Capsules combined with eight-ingredient agarwood powder achieved a total effective rate of 95.56% versus 82.22% for the combination alone (2021). There is also a 60-case observation of the Tibetan medicine thirty-five-ingredient agarwood pill for coronary heart disease. On the animal side, there are separate entries for research on the anti-myocardial ischemia mechanism of eight-ingredient agarwood powder and on Shan agarwood (a Mongolian medicine substitute for agarwood).

2. Two Buckets of Cold Water

First, these are all agarwood-containing compound formulas with small sample sizes—the largest being 90 cases—and efficacy cannot be attributed to agarwood alone. Second, there are no human cardiovascular clinical trials of agarwood as a single agent; animal and in vitro myocardial protection data (early records of water decoction lowering blood pressure and improving myocardial ischemia) are of limited evidence grade. For heart disease, seeing a doctor properly is always the first thing to say; agarwood formulas play a supportive role within the ethnic medicine system, not a replacement.

3. A Note for Agarwood Culture Researchers

The most interesting aspect of this direction is the continuity of the literature: from Song dynasty formularies to Tibetan medical classics to today's clinical reports, the same formula has been in use for over a thousand years without interruption. When creating incense culture content, this timeline itself is the most compelling material.

This article is a review of research literature for academic reference only and does not constitute medical advice or any disease treatment plan. Please consult a doctor for related health issues. Bibliographic information in this article was compiled by the Wubaiyi Agarwood Research Center and the Zhongke Agarwood Standard Technology Research Institute's Collected Agarwood Research Literature series (October 2026); please verify original literature before citing specific data.